Correlation Between E L and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both E L and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining E L and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between E L Financial Corp and Cardiol Therapeutics Class, you can compare the effects of market volatilities on E L and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in E L with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of E L and Cardiol Therapeutics.

Diversification Opportunities for E L and Cardiol Therapeutics

-0.46

Correlation Coefficient

E L  Cardiol Therapeutics

Very good diversification

The 3 months correlation between ELF and Cardiol is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding E L Financial Corp and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and E L is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on E L Financial Corp are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of E L i.e., E L and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between E L and Cardiol Therapeutics

Assuming the 90 days trading horizon E L Financial Corp is expected to generate 0.59 times more return on investment than Cardiol Therapeutics. However, E L Financial Corp is 1.69 times less risky than Cardiol Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.08 per unit of risk. If you would invest  118,581  in E L Financial Corp on December 29, 2024 and sell it today you would earn a total of  13,013  from holding E L Financial Corp or generate 10.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

E L Financial Corp  vs.  Cardiol Therapeutics Class

E L Financial

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in E L Financial Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, E L may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Cardiol Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with E L and Cardiol Therapeutics

The main advantage of trading using opposite E L and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if E L position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind E L Financial Corp and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.